• 1
    Litwin MS, Hays RD, Fink A, et al. Quality of life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 12935.
  • 2
    Brandeis JM, Litwin MS, Burnison CM, Reiter RE. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000; 163: 8517.
  • 3
    Kao T-C, Cruess DF, Garner D, et al. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. J Urol 2000; 163: 85864.
  • 4
    Talcott JA, Rieker P, Clark JA, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J C Oncol 1998; 16: 27583.
  • 5
    Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283: 35460.
  • 6
    Jonler M, Nielsen OS, Wolf H. Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment. Urology 1998; 52: 105563.
  • 7
    McCammon KA, Kolm P, Main B, Schellhammer PF. Comparative quality of life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999; 54: 50916.
  • 8
    Litwin MS, McGuigan KA, Shpall AI, Dhanani N. Recovery of health related quality of life in the year after radical prostatectomy: early experience. J Urol 1999; 161: 5159.
  • 9
    Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 733.
  • 10
    Schwartz EJ, Lepor H. Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms. J Urol 1999; 161: 11858.
  • 11
    Heathcote PS, Mactaggart PN, Boston RJ, James AN, Thompson LC, Nicol DL. Health-related quality of life in Australian men remaining disease-free after radical prostatectomy. Med J Aust 1998; 168: 4836.
  • 12
    Fowler FJ Jr., Roman A, Barry MJ, Wasson J, Lu-Yaom G, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988–1990 (Updated June 1993). Urology 1993;42: 6229.
  • 13
    Braslis KG, Santa-Cruz C, Brickman AL, Soloway MS. Quality of life 12 months after radical prostatectomy. Br J Urol 1995; 75: 4853.
  • 14
    Perez MA, Meyerowitz BE, Lieskovsky G, Skinner DG, Reynolds B, Skinner EC. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids. Urology 1997; 50: 7406.
  • 15
    Fowler FJ Jr., Wasson J, Barry MJ, Roman A, Lu-Yao G, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results for a Medicare survey. Urology 1995;45: 100715.
  • 16
    Fowler FJ, Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three Surveillance, Epidemiology, and End Results areas. J Clin Oncol 1996; 14: 225865.
  • 17
    Lim AJ, Brandon AH, Fielder J, et al. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol 1995; 154: 14205.
  • 18
    Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993; 269: 8737.
  • 19
    Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995; 87: 176776.
  • 20
    Lubeck DP, Litwin MS, Henning JM, Carroll PR. Measurement of health-relation quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res 1997; 6: 38592.
  • 21
    Barry MJ, Fowler FJ, O'Leary MP, et al. Correlation of the American Urological Association Symptom Index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. J Urol 1992; 148: 155863.
  • 22
    Barry MJ, Fowler FJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 154957.
  • 23
    Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey. Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
  • 24
    McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press, 1996.
  • 25
    McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995; 4: 293307.
  • 26
    Ware JE. SF-36 health survey. In: MaruishME, editor. The use of psychological testing for treatment planning and outcomes assessment. 2nd ed. Mahwah, NJ: Lawrence Erlbaum Associates, 1999: 122746.
  • 27
    Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 1992; 305: 1604.
  • 28
    McHorney CA, Ware JE Jr., Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992;30(Suppl): MS25365.
  • 29
    Kempen GIJM, Ormel J, Brilman EI, Relyveld J. Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life. Am J Public Health 1997; 87: 3844.
  • 30
    Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA 1989; 262: 90713.
  • 31
    McHorney CA, Ware JE Jr., Raczek A. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical test of validity in measuring physical and mental health constructs. Med Care 1993;31: 24763.
  • 32
    Ware JE Jr., Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, 1994.
  • 33
    Schag CAC, Heinrich RL. Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990; 4: 1358.
  • 34
    Schag CAC, Ganz PA, Heinrich RL. Cancer rehabilitation evaluation system—short form (CARES-SF): a cancer specific quality of life instrument. Cancer 1991; 68: 140613.
  • 35
    Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 100212.
  • 36
    Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 1994; 23: 9919.
  • 37
    Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000; 56: 899905.